Novel mechanism of resistance to targeted therapies in lung cancer

被引：3
|
作者：
Wang, Walter [1 ]
Carbone, David P. [1 ]
Arasada, Rajeswara Rao [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2019年 / 6卷 / 01期
关键词：
EGFR; Notch3; EGFR TKI; drug persister cells; cancer stem cells; PATHWAY; NOTCH;
D O I：
10.1080/23723556.2018.1551015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We have identified a non-canonical role of0 Notch3 in response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy, whereby Notch3 associates with beta-catenin, resulting in increased catenin beta-1 (CTNNB1, best known as beta-catenin) stability and increased survival of drug persister cells (DPCs). Furthermore, combined treatment of an EGFR TKI with a beta-catenin inhibitor demonstrated improved therapeutic outcomes in xenograft models.
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Novel therapies for lung cancer
    Hoang, T
    Traynor, AM
    Schiller, JH
    SURGICAL ONCOLOGY-OXFORD, 2002, 11 (04): : 229 - 241
  • [32] Targeted therapies for the treatment of lung cancer - Introduction
    Herbst, RS
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S1 - S2
  • [33] Small cell lung cancer and targeted therapies
    Blackhall, Fiona H.
    Shepherd, Frances A.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (02) : 103 - 108
  • [34] New molecularly targeted therapies for lung cancer
    Sun, Sophie
    Schiller, Joan H.
    Spinola, Monica
    Minna, John D.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (10): : 2740 - 2750
  • [35] Targeted therapies in the treatment of lung cancer - Introduction
    Bunn, PA
    Johnson, DH
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 1 - 2
  • [36] Combining Cytotoxic and Targeted Therapies for Lung Cancer
    Zwitter, Matjaz
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1498 - 1499
  • [37] Finding biomarkers of resistance to targeted cancer therapies
    Bernards, Rene
    EJC SUPPLEMENTS, 2007, 5 (05): : 109 - 114
  • [38] Reversing Resistance to Targeted Therapies in Breast Cancer
    Andre, F.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 133 - 133
  • [39] Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer
    Delahaye, Celia
    Figarol, Sarah
    Pradines, Anne
    Favre, Gilles
    Mazieres, Julien
    Calvayrac, Olivier
    CANCERS, 2022, 14 (11)
  • [40] Mechanisms of acquired resistance to targeted cancer therapies
    Lackner, Mark R.
    Wilson, Timothy R.
    Settleman, Jeff
    FUTURE ONCOLOGY, 2012, 8 (08) : 999 - 1014
12345